statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

StockNews.com assumed coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP - Free Report) in a research report report published on Sunday. The firm issued a sell rating on the specialty...

Titan Pharmaceuticals (NASDAQ:TTNP) Receives New Coverage from Analysts at StockNews.com

Titan Pharmaceuticals (NASDAQ:TTNP  Get Free Report) and Alvotech (NYSE:ALVO  Get Free Report) are both medical companies, but which is the superior investment? We will compare the two...

Analyzing Titan Pharmaceuticals (NASDAQ:TTNP) and Alvotech (NYSE:ALVO)

Alvotech (NYSE:ALVO  Get Free Report) and Titan Pharmaceuticals (NASDAQ:TTNP  Get Free Report) are both small-cap medical companies, but which is the superior investment? We will...

Critical Comparison: Titan Pharmaceuticals (NASDAQ:TTNP) versus Alvotech (NYSE:ALVO)

StockNews.com started coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP  Free Report) in a report published on Monday morning. The brokerage issued a sell rating on the specialty...

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Titan Pharmaceuticals trading resumes

StockNews.com assumed coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP  Free Report) in a research report released on Thursday morning. The brokerage issued a sell rating on the...

Titan Pharmaceuticals (NASDAQ:TTNP) Earns Sell Rating from Analysts at StockNews.com

Equities researchers at StockNews.com began coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP  Get Free Report) in a research report issued on Tuesday. The firm set a sell&#8221...

Titan Pharmaceuticals (NASDAQ:TTNP) Research Coverage Started at StockNews.com

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP  Free Report)s stock is scheduled to reverse split on Tuesday, January 9th. The 1-20 reverse split was announced on Tuesday, January 9th. The...

Titan Pharmaceuticals Stock to Reverse Split on Tuesday, January 9th (NASDAQ:TTNP)

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo on February 7, 1992 and is headquartered in South San Francisco, CA.

Volume	1.00
52-Wk High	$16.60
52-Wk Low	$5.00

TTNP Titan Pharmaceuticals, Inc. (de)

About

Feed

News

Fundamentals